New phase III data show Roche’s Vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion (RVO) February 10, 2023February 10, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Positive topline phase III results show Roche's…New two-year data for Roche’s Vabysmo and Susvimo…New two-year data for Roche’s Vabysmo and Susvimo…New two-year data confirm Roche’s Vabysmo improves…The Lancet publishes studies showing Roche’s…The Lancet publishes studies showing Roche’s…
